Vita 34 AG (LTS:0NLV) FCF Margin % : 4.06% (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vita 34 AG's Free Cash Flow for the three months ended in Sep. 2023 was €0.83 Mil. Vita 34 AG's Revenue for the three months ended in Sep. 2023 was €20.41 Mil. Therefore, Vita 34 AG's FCF Margin % for the quarter that ended in Sep. 2023 was 4.06%.

As of today, Vita 34 AG's current FCF Yield % is -5.15%.

The historical rank and industry rank for Vita 34 AG's FCF Margin % or its related term are showing as below:

LTS:0NLV' s FCF Margin % Range Over the Past 10 Years
Min: -15.84 Med: 9.38 Max: 27.43
Current: -6.17

During the past 13 years, the highest FCF Margin % of Vita 34 AG was 27.43%. The lowest was -15.84%. And the median was 9.38%.

LTS:0NLV's FCF Margin % is ranked worse than
67.67% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.385 vs LTS:0NLV: -6.17

Vita 34 AG FCF Margin % Historical Data

The historical data trend for Vita 34 AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG FCF Margin % Chart

Vita 34 AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

18.54

27.43

14.67

1.65

-15.84

Vita 34 AG Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial															-0.82	-33.23	2.36	0.92	4.06

Competitive Comparison of Vita 34 AG's FCF Margin %

For the Medical Care Facilities subindustry, Vita 34 AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vita 34 AG's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vita 34 AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vita 34 AG's FCF Margin % falls into.

Vita 34 AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vita 34 AG's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-10.917	/	68.94
	=	-15.84 %

Vita 34 AG's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0.828	/	20.413
	=	4.06 %

Vita 34 AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita 34 AG (LTS:0NLV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (LTS:0NLV) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

V3V:Germany

Address

Deutscher Platz 5a, Leipzig, DEU, D-04103

Website

https://www.vita34.de

Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.

Vita 34 AG (LTS:0NLV) Headlines

No Headlines